Q32 Bio Inc (QTTB NASDAQ) stock market data APIs
$6.6915
0.28(4.2%)
as of March 20, 2026
Try our APIs with
free plan!
Q32 Bio Inc Financial Data Overview
Price chart is built with
Anychart
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti"interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb " CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.
Prev. Close
6.6915
Open
6.9667
High
7.1003
Low
6.1979
52 wk Range
1.345-7.8
Market Cap
97 725 K
P/E Ratio
2.7603
Shares Outstanding
14 629 K
Revenue
53 737 K
EPS
4.58
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Q32 Bio Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Q32 Bio Inc data using free add-ons & libraries
Get Q32 Bio Inc Fundamental Data
Q32 Bio Inc Fundamental data includes:
- Net Revenue: 53 737 K
- EBITDA: 17 293 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-10
- EPS/Forecast: -0.86
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Q32 Bio Inc News
New
Best Momentum Stocks to Buy for March 19th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 19: FIGS, Inc. FIGS: This healthcare apparel company has a Zacks Rank #1 and witnessed t...
New Strong Buy Stocks for March 19th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: FIGS, Inc. FIGS: This healthcare apparel company has seen the Zacks Consensus Estimate for its current year earnings increasin...
New Strong Buy Stocks for March 13th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Taboola.com Ltd. TBLA: This company which operates as an artificial intelligence-based algorithmic engine platform has seen th...
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
The alopecia areata market is expected to grow significantly as awareness of the condition increases, potentially expanding further in the coming years, supported by rising prevalence. Additionally, t...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
